Alignment Healthcare, Inc.

Fundamentals7.0
Price Action3.5
News Sentiment7.0
AI Rating
6.0

Key Drivers

  • Strong Cash Flow
  • Heavy Leverage
  • Thin Margins

AI
AI Summary

6.0

ALHC is shifting from a pure growth story to a credible scale-and-profitability story, with 33% revenue growth, stronger membership, raised guidance, and positive cash generation, but investors should treat it as a prove-it setup until thin 12% gross margins hold up against Medicare utilization pressure and heavy leverage.

Earnings
ExecutionRisk
Valuation‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

7.0

Key Financial Insights:

  • Strong Cash Flow
  • Heavy Leverage
  • Thin Margins

ALHC improved sequentially with stronger net income and robust free cash flow, but thin 12% margins, heavy leverage, and a rich valuation keep the risk/reward mixed.

CashFlow
Leverage

Price Behavior

3.5
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • Lower highs
  • Weak bounce
  • Tight support

ALHC has shifted from a constructive uptrend to a clear downtrend over the last month, with lower highs/lower lows, key support at $15.70-$16.00, overhead resistance near $20.25-$22.54, and only a reclaim above $18.25-$18.40 signaling stabilization.

ALHC
downtrend
Support Level: $15.70-$16.00
Resistance Level: $20.25-$22.54

Brief rally above $22.00 reversed into a sustained selloff, showing momentum deterioration

Sentiment & News

7.0

Key News Insights:

  • Margin expansion
  • Leadership shift
  • Index inclusion

Alignment Healthcare is showing improving execution as earnings beat estimates, Medicare Advantage costs ease, leadership changes support growth, and S&P SmallCap 600 inclusion plus quality recognition add momentum.

growth
quality

The news is modestly positive for the stock, as improving fundamentals and credibility-building milestones could support valuation and investor interest